BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19

• Press Releases

  SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI

  December 3, 2025

   · 

  10 min read
• Press Releases

  Silexion Therapeutics Receives Positive Feedback from German Health Authority on Design of Phase 2/3 Clinical Trial in Pancreatic Cancer

  December 3, 2025

   · 

  5 min read
• Press Releases

  First U.S. Commercial Sale of KOMZIFTI™ Triggers $135 Million Milestone Payment to Kura Oncology Under Collaboration and License Agreement with Kyowa Kirin

  December 3, 2025

   · 

  2 min read
• Press Releases

  Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S.

  December 3, 2025

   · 

  4 min read
• Press Releases

  Science 37 Receives 2025 Clinical Trials Arena Site Innovation Award for R&D Leadership

  December 3, 2025

   · 

  2 min read
• Press Releases

  Pelthos Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference

  December 3, 2025

   · 

  1 min read
• Press Releases

  Amneal to Participate in Upcoming Investor Conferences - December 2, 2025

  December 3, 2025

   · 

  1 min read
• Press Releases

  Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ Technology for Oligomer-Selective Antibodies and Recruitment Strategies for Phase 2 ALTITUDE-AD Clinical Trial at 18th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference

  December 3, 2025

   · 

  8 min read
• Press Releases

  Oncotelic and Sapu Nano Unveils Broad-Applicability Deciparticle™ Nanomedicine Platform Capable of Formulating Multiple Hydrophobic Peptide, Macrolide, and Polyketide Drugs

  December 3, 2025

   · 

  11 min read
• Press Releases

  Pacira BioSciences Announces Results From 12-Month Pilot Study Demonstrating Favorable Safety and Significant Improvements in Pain With iovera° Compared to Radiofrequency Ablation in Chronic Low Back Pain

  December 3, 2025

   · 

  9 min read